Startup Acquires MacVector From Accelrys, Targets Academic Market for New Release | GenomeWeb
The lead developer of long-time Accelrys offering MacVector has struck out on his own to ensure that the program, which Accelrys sold last year, survives and grows market share.
MacVector, a DNA and protein sequence-analysis package for Apple’s Macintosh platform, is of particular value to academic researchers, boasting more than 5,000 users, according to Kevin Kendall, MacVector’s product manager and lead developer.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.